City of Hope and Cellares recently formed a strategic partnership to revolutionize CAR T Cell Therapy production. This collaboration focuses on automating the manufacturing process for solid tumor treatments. Specifically, the team will evaluate the automated creation of the CARpool program. This program targets glioblastoma, a very aggressive form of brain cancer. The two organizations will use the Cell Shuttle platform for better efficiency.
This partnership represents a major bottleneck in the current oncology market. The price of therapy is very high and comes out to be very time-consuming on the part of the patient. With automation, Cellares can produce far more doses with much higher consistency. The shift makes sure lifesaving CAR T Cell Therapy reaches people much faster compared to earlier. City of Hope provides the deep clinical expertise needed to validate these processes.
Advancing Treatments for Solid Tumors
Most successful cell therapies today focus mainly on blood-based cancers. However, this new initiative targets solid tumors with high precision. Automation reduces the risk of human error during the sensitive production phase. It also allows for the rapid scaling of clinical trials across the country. Consequently, more patients can access these advanced treatments in a shorter timeframe.
“Manual, fragmented manufacturing and quality control cannot meet the scale required for large solid tumor patient populations,” said Fabian Gerlinghaus, CEO of Cellares.“By collaborating with City of Hope, we will remove these bottlenecks through automation, enabling reproducible manufacturing and expanding patient access.”
The Cell Shuttle technology allows for the simultaneous processing of multiple patient batches. This high-throughput capability is essential for global healthcare demands. Both partners remain committed to lowering the total cost of CAR T Cell Therapy. They believe that automation is the only way to meet future needs. This project represents a giant leap forward for the entire biotechnology industry.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
